Phase I Study of Heme Arginate With or Without Tin Mesoporphyrin in Patients With Acute Attacks of Porphyria
Status:
Completed
Trial end date:
2000-05-01
Target enrollment:
Participant gender:
Summary
OBJECTIVES: I. Evaluate the efficacy of tin mesoporphyrin in patients with acute porphyria
attacks who are also treated with a standard course of heme arginate.
II. Evaluate the safety and tolerability of tin mesoporphyrin when administered to these
patients.